Literature DB >> 17126479

Imaging of sellar and parasellar lesions.

Janine Rennert1, Arnd Doerfler.   

Abstract

The sellar and parasellar region is an anatomically complex area where a number of neoplastic, infectious, inflammatory, developmental and vascular pathologies can occur. Differentiation among various etiologies may not always be easy, since many of these lesions may mimic the clinical, endocrinologic and radiologic presentations of pituitary adenomas. The diagnosis of sellar lesions involves a multidisciplinary effort, and detailed endocrinologic, ophthalmologic and neurologic testing are essential. CT and, mainly, MRI are the imaging modalities to study and characterise normal anatomy and the majority of pathologic processes in this region. We here provide an overview of the most relevant MRI and CT characteristics together with clinical findings of pituitary tumors, vascular, inflammatory and infectious lesions found in the sellar/parasellar region in order to propose an appropriate differential diagnosis.

Entities:  

Mesh:

Year:  2006        PMID: 17126479     DOI: 10.1016/j.clineuro.2006.11.001

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  40 in total

1.  Isolated sixth cranial nerve palsy as the presenting symptom of a rapidly expanding ACTH positive pituitary adenoma: a case report.

Authors:  Norman Saffra; Elizabeth Kaplow; Irina Mikolaenko; Alice Kim; Benjamin Rubin; Jafar Jafar
Journal:  BMC Ophthalmol       Date:  2011-01-27       Impact factor: 2.209

2.  Paleopathological findings in radiographs of ancient and modern Greek skulls.

Authors:  Manolis J Papagrigorakis; Kostas G Karamesinis; Kostas P Daliouris; Antonis A Kousoulis; Philippos N Synodinos; Michail D Hatziantoniou
Journal:  Skeletal Radiol       Date:  2012-05-19       Impact factor: 2.199

3.  Accuracy and reproducibility of a novel semi-automatic segmentation technique for MR volumetry of the pituitary gland.

Authors:  Diane M Renz; Horst K Hahn; Peter Schmidt; Jan Rexilius; Markus Lentschig; Alexander Pfeil; Dieter Sauner; Clemens Fitzek; Hans-Joachim Mentzel; Werner A Kaiser; Jürgen R Reichenbach; Joachim Böttcher
Journal:  Neuroradiology       Date:  2010-06-19       Impact factor: 2.804

Review 4.  Childhood craniopharyngioma--current concepts in diagnosis, therapy and follow-up.

Authors:  Hermann L Müller
Journal:  Nat Rev Endocrinol       Date:  2010-09-28       Impact factor: 43.330

5.  The thin sectional anatomy of the sellar region with MRI correlation.

Authors:  Yu Chun Tang; Zhen Mei Zhao; Xiang Tao Lin; Bo Sun; Ling Zhong Fan; Zhong Yu Hou; Heng Tao Qi; Zhen Ping Li; Shu Wei Liu
Journal:  Surg Radiol Anat       Date:  2009-12-13       Impact factor: 1.246

Review 6.  Pediatric sellar and suprasellar lesions.

Authors:  Jason W Schroeder; L Gilbert Vezina
Journal:  Pediatr Radiol       Date:  2011-01-26

7.  Non-adenomatous sellar lesions: experience of a single centre and review of the literature.

Authors:  Maria Koutourousiou; George Kontogeorgos; Andreas Seretis
Journal:  Neurosurg Rev       Date:  2010-05-18       Impact factor: 3.042

8.  Granular cell tumor of the infundibulum: a systematic review of MR-radiography, pathology, and clinical findings.

Authors:  Jessica B Polasek; Yosef Laviv; Fares Nigim; Rafael Rojas; Matthew Anderson; Hemant Varma; Ekkehard M Kasper
Journal:  J Neurooncol       Date:  2018-08-23       Impact factor: 4.130

9.  Possible role of single-voxel (1)H-MRS in differential diagnosis of suprasellar tumors.

Authors:  Mikhail F Chernov; Takakazu Kawamata; Kosaku Amano; Yuko Ono; Takashi Suzuki; Ryoichi Nakamura; Yoshihiro Muragaki; Hiroshi Iseki; Osami Kubo; Tomokatsu Hori; Kintomo Takakura
Journal:  J Neurooncol       Date:  2008-09-30       Impact factor: 4.130

10.  Differentiation between Cystic Pituitary Adenomas and Rathke Cleft Cysts: A Diagnostic Model Using MRI.

Authors:  M Park; S-K Lee; J Choi; S-H Kim; S H Kim; N-Y Shin; J Kim; S S Ahn
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-06       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.